Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Billy R Martin

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|February 18, 2005
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonistsF Ivy Carroll, Wei Ma, Yasuno Yokota, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 31, 2007
Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinolDiana L McKinney, Michael P Cassidy, Lauren M Collier, et al.
Molecular Pharmacology|August 24, 2004
Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptorsM Imad Damaj, F Ivy Carroll, J Brek Eaton, et al.
Journal of Medicinal Chemistry|November 13, 2007
Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidineF Ivy Carroll, T Philip Robinson, Lawrence E Brieaddy, et al.
Bioorganic & Medicinal Chemistry|January 23, 2003
3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptorJohn W Huffman, Ross Mabon, Ming Jung Wu, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indolesJohn W Huffman, Paul V Szklennik, Amanda Almond, et al.
Bioorganic & Medicinal Chemistry|October 30, 2007
Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogsF Ivy Carroll, Yasuno Yokota, Wei Ma, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybridVincenzo Di Marzo, Graeme Griffin, Luciano De Petrocellis, et al.
European Journal of Pharmacology|December 1, 2010
Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonistJenny L Wiley, Christopher S Breivogel, Anu Mahadevan, et al.
British Journal of Pharmacology|November 15, 2005
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosisAlessia Ligresti, Maria Grazia Cascio, Gareth Pryce, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|February 18, 2005
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonistsF Ivy Carroll, Wei Ma, Yasuno Yokota, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 31, 2007
Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinolDiana L McKinney, Michael P Cassidy, Lauren M Collier, et al.
Molecular Pharmacology|August 24, 2004
Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptorsM Imad Damaj, F Ivy Carroll, J Brek Eaton, et al.
Journal of Medicinal Chemistry|November 13, 2007
Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidineF Ivy Carroll, T Philip Robinson, Lawrence E Brieaddy, et al.
Bioorganic & Medicinal Chemistry|January 23, 2003
3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptorJohn W Huffman, Ross Mabon, Ming Jung Wu, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indolesJohn W Huffman, Paul V Szklennik, Amanda Almond, et al.
Bioorganic & Medicinal Chemistry|October 30, 2007
Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogsF Ivy Carroll, Yasuno Yokota, Wei Ma, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybridVincenzo Di Marzo, Graeme Griffin, Luciano De Petrocellis, et al.
European Journal of Pharmacology|December 1, 2010
Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonistJenny L Wiley, Christopher S Breivogel, Anu Mahadevan, et al.
British Journal of Pharmacology|November 15, 2005
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosisAlessia Ligresti, Maria Grazia Cascio, Gareth Pryce, et al.
Pageof 11